These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16040875

  • 21. Determination of maximal voluntary ventilation in children with cystic fibrosis.
    Stein R, Selvadurai H, Coates A, Wilkes DL, Schneiderman-Walker J, Corey M.
    Pediatr Pulmonol; 2003 Jun; 35(6):467-71. PubMed ID: 12746945
    [Abstract] [Full Text] [Related]

  • 22. Anaerobic exercise in pediatric cystic fibrosis.
    Klijn PH, Terheggen-Lagro SW, Van Der Ent CK, Van Der Net J, Kimpen JL, Helders PJ.
    Pediatr Pulmonol; 2003 Sep; 36(3):223-9. PubMed ID: 12910584
    [Abstract] [Full Text] [Related]

  • 23. Preserved diffusion capacity in children with cystic fibrosis.
    Merkus PJ, Govaere ES, Hop WH, Stam H, Tiddens HA, de Jongste JC.
    Pediatr Pulmonol; 2004 Jan; 37(1):56-60. PubMed ID: 14679490
    [Abstract] [Full Text] [Related]

  • 24. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis.
    Robinson PD, Cooper P, Van Asperen P, Fitzgerald D, Selvadurai H.
    Pediatr Pulmonol; 2009 Aug; 44(8):733-42. PubMed ID: 19598271
    [Abstract] [Full Text] [Related]

  • 25. Prognostic value of resting end-tidal carbon dioxide in patients with heart failure.
    Arena R, Peberdy MA, Myers J, Guazzi M, Tevald M.
    Int J Cardiol; 2006 May 24; 109(3):351-8. PubMed ID: 16046017
    [Abstract] [Full Text] [Related]

  • 26. Correlation between parameters of volumetric capnography and spirometry during a submaximal exercise protocol on a treadmill in patients with cystic fibrosis and healthy controls.
    Parazzi PLF, Marson FAL, Ribeiro MAGO, Schivinski CIS, Ribeiro JD.
    Pulmonology; 2019 May 24; 25(1):21-31. PubMed ID: 29954708
    [Abstract] [Full Text] [Related]

  • 27. Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function.
    Bastardo CM, Sonnappa S, Stanojevic S, Navarro A, Lopez PM, Jaffe A, Bush A.
    Thorax; 2009 Mar 24; 64(3):246-51. PubMed ID: 19052050
    [Abstract] [Full Text] [Related]

  • 28. [Cardiopulmonary capacity in patients with mucoviscidosis. Comparison of ergospirometry findings with clinical and radiological scores].
    Friedrichs F, Kusenbach G, Skopnik H, Benz-Bohm G, Döhmen H, Heimann G.
    Monatsschr Kinderheilkd; 1992 Dec 24; 140(12):864-8. PubMed ID: 1491707
    [Abstract] [Full Text] [Related]

  • 29. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers.
    Chien JW, Au DH, Barnett MJ, Goodman GE.
    COPD; 2007 Dec 24; 4(4):339-46. PubMed ID: 18027161
    [Abstract] [Full Text] [Related]

  • 30. End-tidal estimates of arterial PCO2 for cardiac output measurement by CO2 rebreathing: a study in patients with cystic fibrosis and healthy controls.
    Pianosi P, Hochman J.
    Pediatr Pulmonol; 1996 Sep 24; 22(3):154-60. PubMed ID: 8893253
    [Abstract] [Full Text] [Related]

  • 31. Stroke volume during exercise in cystic fibrosis.
    Pianosi P, Pelech A.
    Am J Respir Crit Care Med; 1996 Mar 24; 153(3):1105-9. PubMed ID: 8630552
    [Abstract] [Full Text] [Related]

  • 32. Lung clearance index (LCI) as a predictor of exercise limitation among CF patients.
    Avramidou V, Hatziagorou E, Kampouras A, Hebestreit H, Kourouki E, Kirvassilis F, Tsanakas J.
    Pediatr Pulmonol; 2018 Jan 24; 53(1):81-87. PubMed ID: 28950435
    [Abstract] [Full Text] [Related]

  • 33. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection.
    Bobbio A, Chetta A, Carbognani P, Internullo E, Verduri A, Sansebastiano G, Rusca M, Olivieri D.
    Eur J Cardiothorac Surg; 2005 Nov 24; 28(5):754-8. PubMed ID: 16140541
    [Abstract] [Full Text] [Related]

  • 34. Effect of DNase on exercise capacity in cystic fibrosis.
    Barker M, Franke E, Böhle M, Pfannenstiel C, Heimann G.
    Pediatr Pulmonol; 2004 Jul 24; 38(1):70-4. PubMed ID: 15170876
    [Abstract] [Full Text] [Related]

  • 35. [Assessment of exercise test and bronchial reversibility test as tools for asthma diagnosis in patients with normal spirometry].
    Kuziemski K, Jassem E, Słomiński JM, Ruczyński J.
    Przegl Lek; 2006 Jul 24; 63(12):1269-72. PubMed ID: 17642137
    [Abstract] [Full Text] [Related]

  • 36. Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry.
    Miller MR, Sokol RJ, Narkewicz MR, Sontag MK.
    Liver Transpl; 2012 May 24; 18(5):585-93. PubMed ID: 22271602
    [Abstract] [Full Text] [Related]

  • 37. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
    Waters V, Stanojevic S, Atenafu EG, Lu A, Yau Y, Tullis E, Ratjen F.
    Eur Respir J; 2012 Jul 24; 40(1):61-6. PubMed ID: 22135280
    [Abstract] [Full Text] [Related]

  • 38. Energy cost of activity and exercise in children and adolescents with cystic fibrosis.
    Johnson MR, Ferkol TW, Shepherd RW.
    J Cyst Fibros; 2006 Jan 24; 5(1):53-8. PubMed ID: 16360343
    [Abstract] [Full Text] [Related]

  • 39. Estimation of arterial PCO2 from a lung model during ramp exercise in healthy young subjects.
    Thomas V, Costes F, Busso T.
    Respir Physiol Neurobiol; 2007 Jun 15; 156(3):259-65. PubMed ID: 17166781
    [Abstract] [Full Text] [Related]

  • 40. Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.
    Ren CL, Pasta DJ, Rasouliyan L, Wagener JS, Konstan MW, Morgan WJ, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    J Pediatr; 2008 Dec 15; 153(6):746-51. PubMed ID: 18760805
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.